Welcome to the April Edition of Business Enquirer Magazine – Issue 147
As spring brings a renewed sense of momentum, industries across the globe are moving with greater clarity and intent. This edition reflects a landscape shaped not just by growth, but by meaningful transformation, where innovation is judged by impact and leadership is defined by long-term thinking.
We open with our front cover feature, Gateway to the Caribbean, an in-depth look at the British Virgin Islands Airports Authority (BVIAA) and the critical role aviation plays in sustaining one of the world’s most sought-after destinations. In the British Virgin Islands, aviation is more than infrastructure. It is the lifeline of an economy built on tourism, global mobility and regional connectivity. At the centre is Managing Director Kurt Menal, whose leadership spans operations, strategy and the long-term future of aviation across the territory’s three-airport network. His perspective reflects the reality of a global system where disruption in one region can quickly impact another, reinforcing the importance of resilience and long-term planning.
That same focus on substance over narrative carries through the rest of the edition. Our Top 10 Blockchain Innovators highlights those moving decentralised technology beyond theory and into practical application, reshaping industries through transparency, security and efficiency rather than speculation.
A similar shift can be seen in our feature on Wood, Beyond the Pilot: How Wood Is Making AI Feel Like Engineering. Here, the conversation around artificial intelligence moves away from experimentation and towards measurable operational value. Under the guidance of Scott Ogilvie, AI is embedded within engineering delivery, improving safety, performance and cost efficiency in environments where outcomes matter most.
In parallel, From Vision to Global Leader: How Renaud Dehareng Built a Nuclear Medicine Giant explores transformation within healthcare. Curium’s rise in the radiopharmaceutical sector reflects a disciplined approach to growth, combining strategic acquisition with a clear understanding of where nuclear medicine sits in the future of cancer treatment.
Across each of these features, a consistent theme emerges. Progress is no longer defined by ambition alone, but by execution, resilience and the ability to translate vision into tangible results.
Enjoy the read.